Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Update: Intellia Launch Shows CRISPR Still Excites While Others Struggle

Related Content

Novartis Option Fund licenses option on Viamet's metalloenzyme programme

Feb 24 2010

Zeria/Tillotts in $100m-plus deal for CPP's FAP drug

Jan 13 2014

Year's First 4 IPOs Go South As Proteostasis, AveXis Launch

Feb 13 2016

IPO UPDATE: Bubble worries heighten after another big Alzheimer's offering

Aug 01 2015

Oncobiologics raises $31m for biosimilars; RaNA, Ra, SutroVax add VC cash

Jul 27 2015

Lilly and Novartis put VC cash into Aeglea's series B

Mar 25 2015

FINANCE ROUNDUP: VC Investment Not Hurt Yet By Biotech Stock Slump

Oct 07 2015

TABLE: In turbulent week, 2 IPOs price, 6 test waters

Jul 06 2014

Related Companies

Intellia Therapeutics, Inc.

Editas Medicine

Spring Bank Pharmaceuticals Inc.

Outlook Therapeutics, Inc.

Cancer Prevention Pharmaceuticals, Inc.

Novartis AG

PhaseRx, Inc.

Spyre Therapeutics, Inc.

BioCardia

GenSight Biologics S.A.

Bavarian Nordic A/S

Additional Topics

United States Companies Business Strategies

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window